Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (421-430 of 481) with videos related to

Pageof 49
Sort By:
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Nature Communications|September 21, 2019
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticlePhilip J M Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, et al.
Immunity|April 29, 2014
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersEmilia Falkowska, Khoa M Le, Alejandra Ramos, et al.
Science Translational Medicine|August 10, 2022
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaquesWan-Ting He, Meng Yuan, Sean Callaghan, et al.
Nature|December 23, 2021
Broadly neutralizing antibodies target a haemagglutinin anchor epitopeJenna J Guthmiller, Julianna Han, Henry A Utset, et al.
Cell Reports|June 4, 2026
Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecovirusesKatharina Dueker, Tazio Capozzola, Ziqi Feng, et al.
Biorxiv : the Preprint Server for Biology|July 24, 2020
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2Thomas Mandel Clausen, Daniel R Sandoval, Charlotte B Spliid, et al.
Nature Communications|August 11, 2021
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEMAleksandar Antanasijevic, Leigh M Sewall, Christopher A Cottrell, et al.
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
Science (New York, N.Y.)|May 16, 2024
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodiesZhenfei Xie, Ying-Cing Lin, Jon M Steichen, et al.
Pageof 49

Showing results (421-430 of 481) with videos related to

Sort By:
Pageof 49
Cell Reports|August 24, 2017
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by HyperstabilizationAlba Torrents de la Peña, Jean-Philippe Julien, Steven W de Taeye, et al.
Nature Communications|September 21, 2019
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticlePhilip J M Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, et al.
Immunity|April 29, 2014
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersEmilia Falkowska, Khoa M Le, Alejandra Ramos, et al.
Science Translational Medicine|August 10, 2022
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaquesWan-Ting He, Meng Yuan, Sean Callaghan, et al.
Nature|December 23, 2021
Broadly neutralizing antibodies target a haemagglutinin anchor epitopeJenna J Guthmiller, Julianna Han, Henry A Utset, et al.
Cell Reports|June 4, 2026
Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecovirusesKatharina Dueker, Tazio Capozzola, Ziqi Feng, et al.
Biorxiv : the Preprint Server for Biology|July 24, 2020
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2Thomas Mandel Clausen, Daniel R Sandoval, Charlotte B Spliid, et al.
Nature Communications|August 11, 2021
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEMAleksandar Antanasijevic, Leigh M Sewall, Christopher A Cottrell, et al.
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
Science (New York, N.Y.)|May 16, 2024
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodiesZhenfei Xie, Ying-Cing Lin, Jon M Steichen, et al.
Pageof 49